Evidence map›Paper›PMID 25787755›Full record

ArticleMolecular nutrition & food research2015

Anthocyanins and their physiologically relevant metabolites alter the expression of IL-6 and VCAM-1 in CD40L and oxidized LDL challenged vascular endothelial cells.

Hiren P Amin, Charles Czank, Saki Raheem, Qingzhi Zhang, Nigel P Botting, Aedín Cassidy, Colin D Kay

Open access · hybridAbstract read
In one paragraph

Article in Molecular nutrition & food research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 151 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Effects ofFrontiers in molecular biosciences · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Healthberry 865Nutrients · 2022
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Hiren P AminDepartment of Nutrition, Norwich Medical School, University of East Anglia, Norwich, UK.
Charles CzankDepartment of Nutrition, Norwich Medical School, University of East Anglia, Norwich, UK.
Saki RaheemDepartment of Life Sciences, Faculty of Science and Technology, University of Westminster, London, UK.
Qingzhi ZhangSchool of Chemistry St. Andrews University, Fife, Scotland, UK.
Nigel P BottingSchool of Chemistry St. Andrews University, Fife, Scotland, UK.
Aedín CassidyDepartment of Nutrition, Norwich Medical School, University of East Anglia, Norwich, UK.
Colin D KayDepartment of Nutrition, Norwich Medical School, University of East Anglia, Norwich, UK.
University of East Anglia · GBAndrews University · USUniversity of St Andrews · GBUniversity of Westminster · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H004963/1Biotechnology and Biological Sciences Research Council BB/H532059/1Biotechnology and Biological Sciences Research Council BB/I005943/1Biotechnology and Biological Sciences Research Council BB/I006028/1Biotechnology and Biological Sciences Research Council BB/J004545/1Biotechnology and Biological Sciences Research Council B/H004963/1
6 · The paper itself

Abstract

scopeIn vitro and in vivo studies suggest that dietary anthocyanins modulate cardiovascular disease risk; however, given anthocyanins extensive metabolism, it is likely that their degradation products and conjugated metabolites are responsible for this reported bioactivity. METHODS AND

resultsHuman vascular endothelial cells were stimulated with either oxidized LDL (oxLDL) or cluster of differentiation 40 ligand (CD40L) and cotreated with cyanidin-3-glucoside and 11 of its recently identified metabolites, at 0.1, 1, and 10 μM concentrations. Protein and gene expression of IL-6 and VCAM-1 was quantified by ELISA and RT-qPCR. In oxLDL-stimulated cells the parent anthocyanin had no effect on IL-6 production, whereas numerous anthocyanin metabolites significantly reduced IL-6 protein levels; phase II conjugates of protocatechuic acid produced the greatest effects (>75% reduction, p ≤ 0.05). In CD40L-stimulated cells the anthocyanin and its phase II metabolites reduced IL-6 protein production, where protocatechuic acid-4-sulfate induced the greatest reduction (>96% reduction, p ≤ 0.03). Similarly, the anthocyanin and its metabolites reduced VCAM-1 protein production, with ferulic acid producing the greatest effect (>65% reduction, p ≤ 0.04).

conclusionThese novel data provide evidence to suggest that anthocyanin metabolites are bioactive at physiologically relevant concentrations and have the potential to modulate cardiovascular disease progression by altering the expression of inflammatory mediators.

Indexed as

AnthocyaninsCD40 LigandCoumaric AcidsEndothelial CellsGene ExpressionGlucosidesGlucuronidesHumansHuman Umbilical Vein Endothelial CellsHydroxybenzoatesInterleukin-6Lipoproteins, LDLRNA, MessengerVascular Cell Adhesion Molecule-1AnthocyaninsCD40 LigandCoumaric Acidscyanidin-3-O-beta-glucopyranosideferulic acidGlucosidesGlucuronidesHydroxybenzoatesIL6 protein, humanInterleukin-6Lipoproteins, LDLoxidized low density lipoproteinprotocatechuic acidRNA, MessengerVascular Cell Adhesion Molecule-1Adhesion moleculeCyanidin-3-glucosideCytokineInflammationMetabolites

Identifiers

PMID25787755
PMCPMC4950056
OpenAlexW1966540312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.